• Aucun résultat trouvé

Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary Hypertension

N/A
N/A
Protected

Academic year: 2021

Partager "Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary Hypertension"

Copied!
19
0
0

Texte intégral

Loading

Figure

FIGURE 1 | Expression levels of adenosine receptors and genes associated with adenosine synthesis in pulmonary artery smooth muscle cells (PASMCs) derived from controls and idiopathic pulmonary hypertension (iPAH) lung tissue
FIGURE 2 | Protein levels of adenosine receptors in pulmonary artery smooth muscle cells (PASMCs) derived from controls and idiopathic pulmonary hypertension (iPAH)
FIGURE 3 | Expression levels of adenosine receptors and genes associated with adenosine synthesis in TaglnCre and Adora2b f/f -Tagln Cre mice exposed to hypoxia-SUGEN (HX-SU) or normoxia (NOX)
FIGURE 4 | Expression levels of adenosine receptors and genes associated with adenosine synthesis in TaglnCre and Adora2b f/f− Tagln Cre mice exposed to bleomycin (BLM) or vehicle phosphate-buffered saline (PBS)
+7

Références

Documents relatifs

These are (i) a regression model based on observed nitrate concentrations and additional data on explanatory variables such as soil type, tree species and nitrogen deposition (ii)

The apoptosis observed in ApoE -/- :PAI-1 -/- plaques appears to be dependent on plasminogen activation, as suggested by the six-fold higher plasmin activity detected

At 8 weeks of age, SM22–5-HTT ⫹ mice exhibited PH, with marked increases in right ventricular systolic pressure (RVSP), right ventricle/left ventricle ⫹ septum ratio,

Une partie A d'un espace vectoriel normé est dite compacte si toute suite de points de A admet une suite extraite qui converge dans

different European regions and spine surgeons of the SSE, the study attempted (1) to identify the most important domains determining a good outcome from a patients’ as well as

[r]

Images des pi` eces de monnaie provenantes de la Banque Centrale Europ´

Despite the fact that e flornithine was considered as the safer drug to treat human African trypanosomiasis (HAT) and has been freely available since 2001, the di fficulties in